A national total-body positron emission tomography (PET) imaging platform for drug discovery is launching in the UK next year. It is hoped that the National PET Imaging Platform (NPIP) will transform medical research and industrialise cutting-edge technology, enhancing the quality and speed of drug discovery. Read More
Medicines Discovery Catapult (MDC) has relaunched radiochemistry at the Wolfson Molecular Imaging Centre (WMIC) at the University of Manchester, UK. The facility, which was closed in 2020, includes the multi-million pound ‘Cyclotron’, one of only a few in the UK. It will supply radio-chemicals to drug discovery biotechs and academics,… Read More
By Mette Lauritzen PhD, Product Marketing Manager, Nuclear Molecular Imaging, Bruker BioSpin Different types of tumours, and their varying reactions to treatment, make the search for new effective cancer therapies incredibly challenging. Preclinical in vivo imaging methods are helping to obtain further knowledge of tumour morphology, progression, and biomarker expression… Read More
